Botulinum Toxin in Urology Market By Product Type (OnabotulinumtoxinA, AbobotulinumtoxinA, IncobotulinumtoxinA, RimabotulinumtoxinB, Others), By Indication (Overactive Bladder (OAB), Neurogenic Detrusor Overactivity (NDO), Benign Prostatic Hyperplasia (BPH), Interstitial Cystitis, Urinary Incontinence, Chronic Pelvic Pain Syndrome, Other), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Research & Academic Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• OnabotulinumtoxinA
• AbobotulinumtoxinA
• IncobotulinumtoxinA
• RimabotulinumtoxinB
• Others

By Indication

• Overactive Bladder (OAB)
• Neurogenic Detrusor Overactivity (NDO)
• Benign Prostatic Hyperplasia (BPH)
• Interstitial Cystitis
• Urinary Incontinence
• Chronic Pelvic Pain Syndrome
• Other

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Research & Academic Institutions

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• AbbVie Inc. 
• Merz Pharma GmbH & Co. KGaA 
• Ipsen Pharma 
• Galderma S.A. 
• Evolus, Inc. 
• Medytox 
• Hugel, Inc. 
• Revance Therapeutics, Inc. 
• Daewoong Pharmaceuticals 
• Eisai Co., Ltd. 
• Biovencer Healthcare Pvt Ltd 
• Allergan PLC
• Sun Pharmaceutical Industries Ltd. 
• Lanzhou Institute of Biological Products Co., Ltd. 
• Dermax Medical 
• USWM, LLC 
• Hughs 
• Pharma Research Products Co., Ltd. 
• Jetema Co., Ltd. 
• Toscana Biomarkers S.r.l.